{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:45Z","timestamp":1791910605230,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017539","name":"Theodor Bilharz Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017539","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Antibiotic-resistant methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (MRSA) poses a significant challenge in managing wound infections. Bacteriophage therapy has emerged as a promising alternative or adjunct to traditional antibiotics. This study evaluated the therapeutic potential of a temperate, uncharacterized phage preparation induced from the\n                    <jats:italic>S. aureus<\/jats:italic>\n                    reference strain ATCC 25,923 using mitomycin C (MitC) for topical treatment of superficial MRSA-infected wounds in a rabbit model, both alone and combined with vancomycin. Key wound healing markers (collagen 1, MMP1, PDGF, FGF2) and inflammatory cytokines (IL-1, IL-6, TNF-\u03b1) were assessed alongside immunohistochemical analysis of IL-6 and TNF-\u03b1 expression. The induced lysogenic phage demonstrated lytic activity against MRSA, resulting in a wound healing rate of 87.89%, which increased to 93.63% with combined vancomycin treatment. Enhanced healing correlated with elevated collagen, PDGF, and FGF2 expression and significant downregulation of pro-inflammatory cytokines (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Immunohistochemistry confirmed decreased IL-6 and TNF-\u03b1 expression in wound inflammatory cells. These findings provide preliminary in vivo evidence supporting phage-antibiotic synergy for treating MRSA wounds. Although promising, the phage preparation remains uncharacterized, limiting reproducibility and translational readiness. Further research is needed to characterize active phage components, evaluate safety, and optimize therapeutic protocols before clinical application. This study pioneers the in vivo use of temperate phages combined with antibiotics for MRSA wound treatment, addressing antibiotic resistance issues by improving wound closure, promoting healing factor expression, and reducing inflammation. These results lay an important foundation for developing novel therapies against resistant bacterial infections.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-34474-6","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:45:29Z","timestamp":1770907529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phage-antibiotic synergistic effect for treating cutaneous wounds infections caused by MRSA and the assessment of wound healing biomarkers in a rabbit model"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-0448","authenticated-orcid":false,"given":"Safia","family":"Samir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-245X","authenticated-orcid":false,"given":"Hend","family":"Okasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6686-2442","authenticated-orcid":false,"given":"Tarek","family":"Aboushousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-3264","authenticated-orcid":false,"given":"Abdul Rahman","family":"Abu Seada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-3131","authenticated-orcid":false,"given":"Sami Mohamed","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"34474_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104722","volume":"89","author":"A El-Far","year":"2021","unstructured":"El-Far, A. et al. Assessment of eugenol inhibitory effect on biofilm formation and biofilm gene expression in methicillin resistant Staphylococcus aureus clinical isolates in Egypt. Infect Genet Evol 89, 104722 (2021).","journal-title":"Infect Genet Evol"},{"key":"34474_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1872208315666210121094311","volume":"15","author":"S Samir","year":"2021","unstructured":"Samir, S. Bacteriophages as therapeutic agents: Alternatives to antibiotics. Recent Pat Biotechnol 15, 25\u201333 (2021).","journal-title":"Recent Pat Biotechnol"},{"key":"34474_CR3","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1016\/j.sjbs.2022.03.019","volume":"29","author":"S Samir","year":"2022","unstructured":"Samir, S. et al. Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant Staphylococcus aureus clinical isolates. Saudi J Biol Sci 29, 3097\u20133106 (2022).","journal-title":"Saudi J Biol Sci"},{"key":"34474_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/1872208317666221017094715","volume":"17","author":"S Samir","year":"2023","unstructured":"Samir, S. Basic guidelines for bacteriophage isolation and characterization. Recent Pat Biotechnol 17, 312\u2013331 (2023).","journal-title":"Recent Pat Biotechnol"},{"key":"34474_CR5","doi-asserted-by":"crossref","unstructured":"Liu, C., Hong, Q., Chang, R. Y. K., Kwok, P. C. L., & Chan, H. K. Phage\u2013antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency. Antibiotics. 11 (2022).","DOI":"10.3390\/antibiotics11050570"},{"key":"34474_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-38453-7","volume":"13","author":"M Mardiana","year":"2023","unstructured":"Mardiana, M. et al. Characterization of a novel and active temperate phage vB_AbaM_ABMM1 with antibacterial activity against Acinetobacter baumannii infection. Sci Rep 13, 1\u201313 (2023).","journal-title":"Sci Rep"},{"key":"34474_CR7","doi-asserted-by":"crossref","unstructured":"Gummalla, V. S., Zhang, Y., Liao, Y., Te, & Wu, V. C. H. The role of temperate phages in bacterial pathogenicity. Microorganisms. 11 (2023).","DOI":"10.3390\/microorganisms11030541"},{"key":"34474_CR8","doi-asserted-by":"crossref","unstructured":"Al-anany, A. M., Fatima, R., Nair, G., Mayol, J. T., Hynes, A. P. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny, MBio5. 15, e0050424 (2024).","DOI":"10.1128\/mbio.00504-24"},{"key":"34474_CR9","unstructured":"EDQM. 5.31. Phage therapy medicinal products. Ph. Eur. 11.6 01\/2025:53100. EMA\/CVMP\/NTWP (2023) Guideline on quality, safety and efficacy of veterinary medicinal products specifically designed for phage therapy. 32862\/2022 (2024)."},{"key":"34474_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fmicb.2020.01161","volume":"11","author":"L Bretaudeau","year":"2020","unstructured":"Bretaudeau, L., Tremblais, K., Aubrit, F., Meichenin, M. & Arnaud, I. Good manufacturing practice (GMP) compliance for phage therapy medicinal products. Front. Microbiol. 11, 1161 (2020).","journal-title":"Front. Microbiol."},{"key":"34474_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-1-4939-7395-8_19","volume":"1693","author":"A Fauconnier","year":"2018","unstructured":"Fauconnier, A. Guidelines for bacteriophage product certification. Methods Mol. Biol. 1693, 253\u2013268 (2018).","journal-title":"Methods Mol. Biol."},{"key":"34474_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v10040188","volume":"10","author":"CW Philipson","year":"2018","unstructured":"Philipson, C. W. et al. Characterizing phage genomes for therapeutic applications. Viruses 10, 1\u201320 (2018).","journal-title":"Viruses"},{"key":"34474_CR13","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","volume":"32","author":"JP Pirnay","year":"2015","unstructured":"Pirnay, J. P. et al. Quality and safety requirements for sustainable phage therapy products. Pharm. Res. 32, 2173\u20132179 (2015).","journal-title":"Pharm. Res."},{"key":"34474_CR14","doi-asserted-by":"crossref","unstructured":"Rohde, C., Resch, G., Pirnay, J. P., Blasdel, B. G., Debarbieux, L., Gelman, D., G\u00f3rski, A., Hazan, R., Huys, I., Kakabadze, E., \u0141obocka, M., Maestri, A., Almeida, G. M. D. F., Makalatia, K., Malik, D. J., Ma\u0161la\u0148ov\u00e1, I., Merabishvili, M., Pantucek, R., Rose, T., \u0160tver\u00e1kov\u00e1, D., Van Raemdonck, H., Verbeken, G., Chanishvili, N. Expert opinion on three phage therapy related topics: Bacterial phage resistance, phage training and prophages in bacterial production strains. Viruses 10 (2018).","DOI":"10.3390\/v10040178"},{"key":"34474_CR15","doi-asserted-by":"publisher","first-page":"e01209","DOI":"10.1128\/AEM.01209-19","volume":"85","author":"KV Sergueev","year":"2019","unstructured":"Sergueev, K. V. et al. Correlation of host range expansion of therapeutic bacteriophage Sb-1 with allele state at a hypervariable repeat locus. Appl. Env. Microbiol. 85, e01209-e1219 (2019).","journal-title":"Appl. Env. Microbiol."},{"issue":"6","key":"34474_CR16","doi-asserted-by":"publisher","first-page":"26717","DOI":"10.1038\/srep26717","volume":"6","author":"BK Chan","year":"2016","unstructured":"Chan, B. K. et al. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci. Rep. 6(6), 26717 (2016).","journal-title":"Sci. Rep."},{"key":"34474_CR17","doi-asserted-by":"publisher","first-page":"1401234","DOI":"10.3389\/fmicb.2024.1401234","volume":"15","author":"J Fujiki","year":"2024","unstructured":"Fujiki, J., Nakamura, K., Ishiguro, Y. & Iwano, H. Using phage to drive selections toward restoring antibiotic sensitivity in Pseudomonas aeruginosa via chromosomal deletions. Front. Microbiol. 15, 1401234 (2024).","journal-title":"Front. Microbiol."},{"key":"34474_CR18","first-page":"1","volume":"16","author":"A Tarasenko","year":"2025","unstructured":"Tarasenko, A. et al. Reprogramming resistance\u202f: Phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens. Bacteriophages 16, 1\u201315 (2025).","journal-title":"Bacteriophages"},{"key":"34474_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics11070839","volume":"11","author":"K Diallo","year":"2022","unstructured":"Diallo, K. & Dublanchet, A. Benefits of combined phage-antibiotic therapy for the control of antibiotic-resistant bacteria: A literature review. Antibiotics 11, 1\u201311 (2022).","journal-title":"Antibiotics"},{"key":"34474_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/0109298665181166231212051621","volume":"31","author":"S Samir","year":"2024","unstructured":"Samir, S. Molecular machinery of the triad holin, endolysin, and spanin: Key players orchestrating bacteriophage-induced cell lysis and their therapeutic applications. Protein Pept. Lett. 31, 85\u201396 (2024).","journal-title":"Protein Pept. Lett."},{"key":"34474_CR21","first-page":"1","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee, A. S. et al. Methicillin-resistant Staphylococcus aureus. Nat. Rev. Dis. Prim. 4, 1\u201323 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"34474_CR22","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.2147\/IDR.S335582","volume":"14","author":"A El-Far","year":"2021","unstructured":"El-Far, A. et al. High rates of aminoglycoside methyltransferases associated with metallo-beta-lactamases in multidrug-resistant and extensively drug-resistant pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt. Infect Drug Resist. 14, 4849\u20134858 (2021).","journal-title":"Infect Drug Resist."},{"key":"34474_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells12010199","volume":"12","author":"SJ Wood","year":"2023","unstructured":"Wood, S. J., Kuzel, T. M. & Shafikhani, S. H. Pseudomonas aeruginosa: Infections, animal modeling, and therapeutics. Cells 12, 1\u201337 (2023).","journal-title":"Cells"},{"key":"34474_CR24","doi-asserted-by":"crossref","unstructured":"Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., Bolger, A. F., Steckelberg, J. M., Baltimore, R. S., Fink, A. M., O\u2019Gara, P., & Taubert, K. A. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart AssociationCirculation (2015).","DOI":"10.1161\/CIR.0000000000000296"},{"key":"34474_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.18683\/germs.2018.1138","volume":"8","author":"TM Khan","year":"2018","unstructured":"Khan, T. M. et al. Incidence of methicillin resistant staphylococcus aureus (MRSA) in burn intensive care unit: A systematic review. Germs 8, 113\u2013125 (2018).","journal-title":"Germs"},{"key":"34474_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","volume":"21","author":"Y Cong","year":"2020","unstructured":"Cong, Y., Yang, S. & Rao, X. Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. J. Adv. Res. 21, 169\u2013176 (2020).","journal-title":"J. Adv. Res."},{"key":"34474_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23092392","volume":"23","author":"I Negut","year":"2018","unstructured":"Negut, I., Grumezescu, V. & Grumezescu, A. M. Treatment strategies for infected wounds. Molecules 23, 1\u201323 (2018).","journal-title":"Molecules"},{"key":"34474_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/bs.pmbts.2023.03.027","volume":"200","author":"S Samir","year":"2023","unstructured":"Samir, S. Phages for treatment of Staphylococcus aureus infection. Prog. Mol. Biol. Transl. Sci. 200, 275\u2013302 (2023).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"34474_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12223-021-00946-1","volume":"67","author":"A Zyman","year":"2022","unstructured":"Zyman, A., G\u00f3rski, A. & Mi\u0119dzybrodzki, R. Phage therapy of wound-associated infections. Folia Microbiol (Praha) 67, 193\u2013201 (2022).","journal-title":"Folia Microbiol (Praha)"},{"key":"34474_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/antibiotics13090800","volume":"13","author":"G Santamar","year":"2024","unstructured":"Santamar, G., Aguilera-correa, J. J., Esteban, J. & Garc, M. Bacteriophage therapy on an in vitro wound model and synergistic effects in combination with beta-lactam antibiotics. Antibiot 13, 800 (2024).","journal-title":"Antibiot"},{"key":"34474_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.14737\/journal.aavs\/2016\/4.11.593.603","volume":"4","author":"OMS Ibrahim","year":"2016","unstructured":"Ibrahim, O. M. S., Sarhan, S. R. & Salih, S. I. Activity of isolated staphylococcal bacteriophage in treatment of experimentally induced chronic osteomyelitis in rabbits. Adv. Anim. Vet. Sci. 4, 593\u2013603 (2016).","journal-title":"Adv. Anim. Vet. Sci."},{"key":"34474_CR32","first-page":"1","volume":"5","author":"G Rahimzadeh","year":"2017","unstructured":"Rahimzadeh, G., Gill, P. & Rezai, M. S. Characterization of methicillin-resistant Staphylococcus aureus (MRSA) phages from sewage at a tertiary pediatric hospital. Arch. Pediatr. Infect. Dis. 5, 1\u20137 (2017).","journal-title":"Arch. Pediatr. Infect. Dis."},{"key":"34474_CR33","first-page":"1","volume":"12","author":"V Abat\u00e1ngelo","year":"2017","unstructured":"Abat\u00e1ngelo, V. et al. Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strains. PLoS ONE 12, 1\u201322 (2017).","journal-title":"PLoS ONE"},{"key":"34474_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmrp.2018.01.001","volume":"8","author":"SS Boswihi","year":"2018","unstructured":"Boswihi, S. S. & Udo, E. E. Methicillin-resistant Staphylococcus aureus\u202f: An update on the epidemiology, treatment options and infection control. Curr. Med. Res. Pract. 8, 18\u201324 (2018).","journal-title":"Curr. Med. Res. Pract."},{"key":"34474_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.907314","volume":"12","author":"L Plumet","year":"2022","unstructured":"Plumet, L. et al. Bacteriophage therapy for staphylococcus aureus infections: A review of animal models, treatments, and clinical trials. Front. Cell Infect. Microbiol. 12, 1\u201316 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"34474_CR36","doi-asserted-by":"publisher","first-page":"1554182","DOI":"10.3389\/fmicb.2025.1554182","volume":"16","author":"L Ma","year":"2025","unstructured":"Ma, L. et al. Isolation and characterization of methicillin-resistant Staphylococcus aureus phage SPB against MRSA planktonic cells and biofilm. Front. Microbiol. 16, 1554182 (2025).","journal-title":"Front. Microbiol."},{"key":"34474_CR37","doi-asserted-by":"crossref","unstructured":"Krusche, J., Beck, C., Lehmann, E., Silvia, W., Wolz, C., Peschel, A. Resource Characterization and host range prediction of Staphylococcus aureus phages through receptor- binding protein analysis ll ll Characterization and host range prediction of Staphylococcus aureus phages through receptor-binding protein analysis. Cell Reports Cell Press 44 (2025).","DOI":"10.1016\/j.celrep.2025.115369"},{"key":"34474_CR38","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1021\/jacs.1c01275","volume":"143","author":"M Jancheva","year":"2021","unstructured":"Jancheva, M. & B\u00f6ttcher, T. A metabolite of pseudomonas triggers prophage-selective lysogenic to lytic conversion in staphylococcus aureus. J. Am. Chem. Soc. 143, 8344\u20138351 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"34474_CR39","doi-asserted-by":"publisher","unstructured":"Nepal, R., Houtak, G., Bouras, G., Ramezanpour, M., Feizi, S., Shaghayegh, G., Shearwin, K., Psaltis, A. J., Wormald, P. J. & Vreugde, S. Prophage acquisition by Staphylococcus aureus contributes to the expansion of Staphylococcal immune evasion https:\/\/doi.org\/10.1101\/2023.04.27.538627 (2023).","DOI":"10.1101\/2023.04.27.538627"},{"key":"34474_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27037-6","volume":"12","author":"PC G\u00f6ller","year":"2021","unstructured":"G\u00f6ller, P. C. et al. Multi-species host range of staphylococcal phages isolated from wastewater. Nat. Commun. 12, 1\u201317 (2021).","journal-title":"Nat. Commun."},{"key":"34474_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4161\/bact.22111","volume":"2","author":"J Klumpp","year":"2012","unstructured":"Klumpp, J., Fouts, D. E. & Sozhamannan, S. Next generation sequencing technologies and the changing landscape of phage genomics. Bacteriophage 2, 190\u2013199 (2012).","journal-title":"Bacteriophage"},{"issue":"5","key":"34474_CR42","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.3390\/ijms24054483","volume":"24","author":"M Kornienko","year":"2023","unstructured":"Kornienko, M. et al. PCR assay for rapid taxonomic differentiation of virulent staphylococcus aureus and klebsiella pneumoniae bacteriophages. Int. J. Mol. Sci. 24(5), 4483 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"34474_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mSystems.00542-20","volume":"5","author":"J-F Huon","year":"2020","unstructured":"Huon, J.-F. et al. Phages versus antibiotics to treat infected diabetic wounds in a mouse model: A microbiological and microbiotic evaluation. Msystems 5(6), 1\u201313 (2020).","journal-title":"Msystems"},{"key":"34474_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v15020460","volume":"15","author":"H Joo","year":"2023","unstructured":"Joo, H. et al. Phage and antibiotic combinations reduce staphylococcus aureus in static and dynamic biofilms grown on an implant material. Viruses 15, 1\u201314 (2023).","journal-title":"Viruses"},{"key":"34474_CR45","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1128\/AEM.00056-06","volume":"72","author":"F Chene","year":"2006","unstructured":"Chene, F., Wang, K., Stewart, J. & Belas, R. Induction of multiple prophages from a marine bacterium: A genomic approach. Appl. Environ. Microbiol. 72, 4995\u20135001 (2006).","journal-title":"Appl. Environ. Microbiol."},{"key":"34474_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-022-03501-3","volume":"18","author":"F Mohammadian","year":"2022","unstructured":"Mohammadian, F., Rahmani, H. K., Bidarian, B. & Khoramian, B. Isolation and evaluation of the efficacy of bacteriophages against multidrug-resistant (MDR), methicillin-resistant (MRSA) and biofilm-producing strains of Staphylococcus aureus recovered from bovine mastitis. BMC Vet. Res. 18, 1\u201311 (2022).","journal-title":"BMC Vet. Res."},{"key":"34474_CR47","doi-asserted-by":"crossref","unstructured":"Loganathan, A., Manohar, P., & Nachimuthu, R. Phage-antibiotic combination: An effective method for eradication of staphylococcus aureus. bioRxiv 2023.03.27.534482 (2023).","DOI":"10.1101\/2023.03.27.534482"},{"key":"34474_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/iep.12346","volume":"101","author":"DS Masson-Meyers","year":"2020","unstructured":"Masson-Meyers, D. S. et al. Experimental models and methods for cutaneous wound healing assessment. Int. J. Exp. Pathol. 101, 21\u201337 (2020).","journal-title":"Int. J. Exp. Pathol."},{"key":"34474_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-33294-w","volume":"13","author":"B Van Nieuwenhuyse","year":"2022","unstructured":"Van Nieuwenhuyse, B. et al. Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler. Nat. Commun. 13, 1\u201312 (2022).","journal-title":"Nat. Commun."},{"key":"34474_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/spectrum.00341-23","volume":"11","author":"J Luo","year":"2023","unstructured":"Luo, J. et al. Synergistic antibacterial effect of phage pB3074 in combination with antibiotics targeting cell wall against multidrug-resistant acinetobacter baumannii in vitro and ex vivo. Microbiol. Spectr. 11, 1\u201311 (2023).","journal-title":"Microbiol. Spectr."},{"key":"34474_CR51","unstructured":"Li, H., Gan, D., Wang, M., Deng, H., Yang, Q. E., Li, H., Gan, D., Wang, M., Deng, H. & Yang, Q. E. Synergy against pathogenic Klebsiella pneumoniae 9, 1\u201314 (2024)."},{"issue":"2","key":"34474_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/v13020334","volume":"13","author":"BL Aghaee","year":"2021","unstructured":"Aghaee, B. L., Khan Mirzaei, M., Alikhani, M. Y., Mojtahedi, A. & Maurice, C. F. Improving the inhibitory effect of phages against pseudomonas aeruginosa isolated from a burn patient using a combination of phages and antibiotics. Viruses 13(2), 334 (2021).","journal-title":"Viruses"},{"issue":"11","key":"34474_CR53","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/bioengineering9110712","volume":"9","author":"C Tyavambiza","year":"2022","unstructured":"Tyavambiza, C., Meyer, M. & Meyer, S. Cellular and molecular events of wound healing and the potential of silver based nanoformulations as wound healing agents. Bioengineering 9(11), 712 (2022).","journal-title":"Bioengineering"},{"key":"34474_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.addr.2018.09.010","volume":"146","author":"AP Veith","year":"2019","unstructured":"Veith, A. P., Henderson, K., Spencer, A. & Sligar, A. D. B. A. Therapeutic strategies for enhancing angiogenesis in wound healing. Adv. Drug. Deliv. Rev. 146, 97\u2013125 (2019).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"34474_CR55","doi-asserted-by":"crossref","unstructured":"Mathew-Steiner, S. S, Roy, S., Sen, C. K. Collagen in wound healing. Bioengineering 8 (2021).","DOI":"10.3390\/bioengineering8050063"},{"key":"34474_CR56","first-page":"1","volume":"9","author":"A Loganathan","year":"2024","unstructured":"Loganathan, A., Bozdogan, B., Manohar, P. & Morales, S. P. Phage-antibiotic combinations in various treatment modalities to manage MRSA infections. Front Pharmacol 9, 1\u201311 (2024).","journal-title":"Front Pharmacol"},{"key":"34474_CR57","doi-asserted-by":"crossref","unstructured":"Huon, J-F, Montassier, E. LA-G., Gr\u00e9goire, M., Vibet, M-A., Caillon, J. B. D. D. N. Phages versus antibiotics to treat infected diabetic wounds in a mouse model: A microbiological and microbiotic evaluation. mSystems 5, e00542\u201320 (2020).","DOI":"10.1128\/mSystems.00542-20"},{"key":"34474_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2024.1384164","volume":"15","author":"A Subramanian","year":"2024","unstructured":"Subramanian, A. Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance. Front. Microbiol. 15, 1\u201316 (2024).","journal-title":"Front. Microbiol."},{"key":"34474_CR59","first-page":"1","volume":"14","author":"M Zhang","year":"2022","unstructured":"Zhang, M., Zhang, T., Yu, M., Chen, Y. L. & Jin, M. The life cycle transitions of temperate phages: Regulating factors and potential ecological implications. Viruses 14, 1\u201320 (2022).","journal-title":"Viruses"},{"key":"34474_CR60","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/cimb45020076","volume":"45","author":"S Zhou","year":"2023","unstructured":"Zhou, S., Liu, Z., Song, J. & Chen, Y. Disarm the bacteria: What Temperate phages can do. Curr. Issues Mol. Biol. 45, 1149\u20131167 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"34474_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/qjmed\/hcy200.117","volume":"111","author":"WK Zaki","year":"2018","unstructured":"Zaki, W. K. & Hager, R. Detection of methicillin resistant Staphylococcus aureus, vancomycin intermediate susceptibility and vancomycin resistance among Staphylococcus aureus isolated from tertiary care hospital. QJM An. Int. J. Med. 111, 53\u201358 (2018).","journal-title":"QJM An. Int. J. Med."},{"key":"34474_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13756-016-0126-3","volume":"5","author":"AO Kshetry","year":"2016","unstructured":"Kshetry, A. O. et al. Minimum inhibitory concentration of vancomycin to methicillin resistant Staphylococcus aureus isolated from different clinical samples at a tertiary care hospital in Nepal. Antimicrob. Resist. Infect. Control 5, 4\u20139 (2016).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"34474_CR63","first-page":"1","volume":"19","author":"ACC De Melo","year":"2019","unstructured":"De Melo, A. C. C. et al. Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals. BMC Microbiol. 19, 1\u201315 (2019).","journal-title":"BMC Microbiol."},{"key":"34474_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101543","volume":"8","author":"P Bellio","year":"2021","unstructured":"Bellio, P., Fagnani, L., Nazzicone, L. & Celenza, G. New and simplified method for drug combination studies by checkerboard assay. MethodsX 8, 101543 (2021).","journal-title":"MethodsX"},{"key":"34474_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/1735-3327.92960","volume":"9","author":"B Thomas","year":"2012","unstructured":"Thomas, B., Bhat, K. & Mapara, M. Rabbit as an animal model for experimental research. Dent. Res. J. (Isfahan) 9, 111 (2012).","journal-title":"Dent. Res. J. (Isfahan)"},{"key":"34474_CR66","first-page":"1","volume":"1","author":"N Rezk","year":"2022","unstructured":"Rezk, N. et al. Bacteriophage as a potential therapy to control antibiotic - resistant Pseudomonas aeruginosa infection through topical application onto a full - thickness wound in a rat model. J Genet. Eng. Biotechnol. 1, 1\u201316 (2022).","journal-title":"J Genet. Eng. Biotechnol."},{"key":"34474_CR67","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1258\/0023677011911561","volume":"35","author":"P Hedenqvist","year":"2001","unstructured":"Hedenqvist, P., Roughan, J. V., Antunes, L. & Orr, H. F. P. Induction of anaesthesia with desflurane and isoflurane in the rabbit. Lab. Anim. 35, 172\u2013179 (2001).","journal-title":"Lab. Anim."},{"key":"34474_CR68","unstructured":"Khan, J. & Liu, M. Desflurane. [Updated 2022 Jun 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537106."},{"key":"34474_CR69","unstructured":"Miller, A. L., Theodore, D. & Widrich J. Inhalational Anesthetic. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554540\/."},{"key":"34474_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1751-0813.2008.00285.x","volume":"86","author":"S Lomax","year":"2008","unstructured":"Lomax, S., Sheil, M. & Windsor, P. A. Impact of topical anaesthesia on pain alleviation and wound healing in lambs after mulesing. Aust Vet J 86, 159\u2013168 (2008).","journal-title":"Aust Vet J"},{"key":"34474_CR71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jclinane.2012.09.004","volume":"25","author":"G Khalili","year":"2013","unstructured":"Khalili, G., Janghorbani, M., Saryazdi, H. & Emaminejad, A. Effect of preemptive and preventive acetaminophen on postoperative pain score: A randomized, double-blind trial of patients undergoing lower extremity surgery. J. Clin. Anesth. 25, 188\u2013192 (2013).","journal-title":"J. Clin. Anesth."},{"key":"34474_CR72","first-page":"785","volume":"148","author":"J Witowski","year":"2024","unstructured":"Witowski, J., Sikorska, D. & Catar, R. Reporting practices for animal studies on peritoneal dialysis conducted in 2021\u20132023 after the Introduction of the ARRIVE 2. 0 guidelines. Nephron 148, 785\u2013795 (2024).","journal-title":"Nephron"},{"key":"34474_CR73","doi-asserted-by":"crossref","unstructured":"Flitti, D., Pandis, N., & Seehra, J. Still to ARRIVE at adequate reporting of orthodontic studies involving animal models. Eur. J. Orthod. 46:cjae032 (2024).","DOI":"10.1093\/ejo\/cjae032"},{"key":"34474_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/00236772231181658","volume":"58","author":"J Song","year":"2024","unstructured":"Song, J., Solmi, M. & Carvalho, A. F. Twelve years after the ARRIVE guidelines: animal research has not yet arrived at high standards. Lab. Anim. 58, 109\u2013115 (2024).","journal-title":"Lab. Anim."},{"key":"34474_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo, A. et al. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE 15, 1\u201314 (2020).","journal-title":"PLoS ONE"},{"key":"34474_CR76","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1369\/0022155414545787","volume":"62","author":"R Lattouf","year":"2014","unstructured":"Lattouf, R. et al. Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues. J. Histochem. Cytochem. 62, 751\u2013758 (2014).","journal-title":"J. Histochem. Cytochem."},{"key":"34474_CR77","doi-asserted-by":"crossref","unstructured":"El-zahed, E. S. E., Othman, A. M. A., & Ahmed, S. M. Role of interleukin 6 and tumor necrosis factor alpha in determination of skin wound age in human cadavers: histopathological and immunohistochemical study 18:92\u2013107 (2020).","DOI":"10.21608\/zjfm.2019.14822.1035"},{"key":"34474_CR78","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao, X., Huang, X., Zhou, Z. & Lin, X. An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat. Bioinf. Biomath. 3, 71\u201385 (2013).","journal-title":"Biostat. Bioinf. Biomath."},{"key":"34474_CR79","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1872208314666201112105053","volume":"15","author":"MA Saber","year":"2021","unstructured":"Saber, M. A., Okasha, H., Khorshed, F. & Samir, S. A novel cell-based in vitro assay for antiviral activity of interferons \u03b1, \u03b2, and \u03b3 by qPCR of MxA gene expression. Recent Pat. Biotechnol. 15, 67\u201375 (2021).","journal-title":"Recent Pat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34474-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:04:14Z","timestamp":1770984254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34474-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34474"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34474-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in this study, including handling, anesthesia, and sacrifice, adhered to the ethical guidelines approved by the Ethical Committee of the Federal Legislation and the National Institutes of Health Guidelines in the United States. All animal experiments were carried out under Institutional Ethical Committee rules for the care and use of experimental animals, which were authorized by Theodor Bilharz Research Institute\u2019s Animal Ethics Committee in Giza, Egypt (FWA 00010609). All methods are documented in line with the ARRIVE guidelines for reporting animal experiments. (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6337"}}